• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

News & Events

  • Print
  • Share
  • E-mail

Section Contents Menu

Newsroom

2009 Media Transcripts

Transcript of FDA's Media Briefing on the Label Update for the Drug Plavix (clopidogrel)

 

Transcript of FDA's Media Briefing on Caffeinated Alcohol Drinks

 

Transcript of FDA's Media Briefing on Front-of-Pack Labeling

 

Transcript of FDA's Media Briefing on the FDA's Review of the ReGen Menaflex

 

Transcript of FDA's Media Briefing on Ban on Cigarettes with Certain Characterizing Flavors


Transcript of FDA's Media Briefing on Expanded Access to Investigational Drugs


Transcript of FDA’s Media Briefing on its Warning to Consumers Not to Use Body Building Products Marketed as Containing Steroids or Steroid-Like Substances


Transcript of FDA's Media Briefing on Electronic Cigarettes

 

Transcript of FDA's Media Briefing on the Regulation to Improve Egg Safety and Reduce Salmonella Illness

 

Transcript of FDA's Media Briefing on the Serious Mental Health Risks Associated With the Drugs Chantix and Zyban

Transcript of FDA's Media Briefing on the Public Health Problem of Liver Injury Related to the Use of Acetaminophen in Both Over-the-Counter (OTC) and Prescription Products


Transcript of FDA's Media Briefing on Seizure of Drug Products Manufactured by Caraco Pharmaceutical Laboratories Limited


Transcript of FDA Media Briefing on FDA’s Advice to Consumers Not to Use Certain Zicam Cold Remedies

 

Transcript of FDA's Media Briefing on an Ongoing Review of Stimulant Medications Used in Children with ADHD

 

Transcript of FDA's Media Briefing on FDA Transparency Task Force

 

Transcript of FDA's Media Briefing on Risk Evaluation of Long-Acting Opioid Drugs

 

Transcript of FDA's Media Briefing on Hydroxycut Dietary Supplement

 

Transcript of FDA's Media Briefing on Botulinum Toxin Products

 

Transcript of FDA's Media Briefing on the Pistachio Recall Investigation 

 

Transcript of FDA's Media Briefing Warning about the Risk of a Skin Burn When Patients Wear a Medication Patch During an MRI

 

Transcript of FDA's Media Briefing on the Safe Use of Opioids

 

Transcripts of FDA's Media Briefing on the Update on the Salmonella Typhimurium Outbreak

 

Transcript of FDA’s Media Briefing on FDA's Release of a Final Guidance for Industry on the Regulation of Genetically-Engineered Animals